ince its advent, transition metal-catalysed cross-coupling has revolutionized the art of chemical synthesis [1][2][3][4] . By offering a direct avenue for the union of two or more entities to generate molecular complexity, the field has far-ranging applications across academia and industry 5 . In recent years, the renaissance of non-precious base metal catalysis 6-8 has stimulated remarkable developments in cross-coupling by enabling a broader set of organic precursors to be merged to access new chemical space that is often unattainable by noble-metal-based catalysts 9,10 . In particular, the use of catalysts derived from non-toxic iron, the most abundant and inexpensive transition metal in the Earth's crust [11][12][13] , is naturally appealing to chemists for economic and environmental reasons. Although iron-catalysed cross-coupling 14,15 has seen substantial progress in recent years, the developments in this area and its utility in organic synthesis are still pale in comparison with those of the more established transition metals, such as palladium 16 . This owes, in part, to iron's ability to adopt a large number of oxidation states and spin states 17,18 , which consequently elevates the difficulty of manipulating organoiron chemistry to facilitate C−C bond formation. However, iron-catalysed reactions between two bench-stable electrophilic substrates 19 , which would effectively eliminate the requirement for unstable and basic organometallic reagents 20 , are scarce and underdeveloped.In light of the aforementioned challenges, it is unsurprising that iron catalysis is rarely employed in the context of complex C-glycoside synthesis [21][22][23][24][25][26][27] . Stereochemically pure glycosides with a functionalized alkenyl, alkynyl or heteroaryl substituent on the anomeric carbon play vital roles in various studies that pertain to biological functions 28,29 and diseases 30 (Fig. 1a). These motifs are embedded within the frameworks of countless therapeutically